305 related articles for article (PubMed ID: 32058624)
1. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
[TBL] [Abstract][Full Text] [Related]
2. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.
Guo Q; Cheng Y; Liang T; He Y; Ren C; Sun L; Zhang G
Sci Rep; 2015 Dec; 5():17683. PubMed ID: 26631459
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
5. Differential long noncoding RNAs expression in cancer-associated fibroblasts of non-small-cell lung cancer.
Teng C; Huang G; Luo Y; Pan Y; Wang H; Liao X; Li Y; Yang J
Pharmacogenomics; 2019 Feb; 20(3):143-153. PubMed ID: 30808275
[TBL] [Abstract][Full Text] [Related]
6. The Role of Long Non-Coding RNAs in Ovarian Cancer.
Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
[TBL] [Abstract][Full Text] [Related]
8. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
[TBL] [Abstract][Full Text] [Related]
10. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
12. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer.
Guo Q; He Y; Sun L; Kong C; Cheng Y; Wang P; Zhang G
J Cell Mol Med; 2019 Mar; 23(3):1840-1851. PubMed ID: 30549251
[TBL] [Abstract][Full Text] [Related]
14. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
15. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
Zou T; Wang PL; Gao Y; Liang WT
Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
19. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
Walters K; Sarsenov R; Too WS; Hare RK; Paterson IC; Lambert DW; Brown S; Bradford JR
BMC Genomics; 2019 Jun; 20(1):454. PubMed ID: 31159744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
